Cargando…
Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review
Erlotinib is among the oral EGFR-tyrosine kinase inhibitors used to treat non-small cell lung cancer. The common side effects of erlotinib include acne form rash and diarrhea. Eyelash trichomegaly and alterations of scalp hair are rarely observed symptoms. In the present study, we report changes in...
Autores principales: | Zheng, Hua, Zhang, Hongmei, Zhang, Tongmei, Wang, Qunhui, Hu, Fanbin, Li, Baolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998076/ https://www.ncbi.nlm.nih.gov/pubmed/27588051 http://dx.doi.org/10.3892/etm.2016.3460 |
Ejemplares similares
-
Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013) -
Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
por: Goel, Varun, et al.
Publicado: (2014) -
Eyelash Trichomegaly
por: Kaur, Sandeep, et al.
Publicado: (2015) -
Essential Trichomegaly of the Eyelashes
por: Fernández-Crehuet, Pablo, et al.
Publicado: (2016) -
Eyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy
por: Agrawal, Chaturbhuj R, et al.
Publicado: (2018)